心血管-肝脏-代谢健康:通过改进德尔菲法筛查、诊断和管理心血管疾病中代谢功能障碍相关脂肪变性肝病的建议

IF 35.5 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Nicholas W S Chew,Anurag Mehta,Rachel Sze Jen Goh,Audrey Zhang,Yiming Chen,Bryan Chong,Han Shi Jocelyn Chew,Asim Shabbir,Adrian Brown,Georgios K Dimitriadis,Daniel Q Huang,Roger Foo,Carel W le Roux,Gemma A Figtree,Marat Fudim,Ambarish Pandey,Mamas A Mamas,Derek J Hausenloy,A Mark Richards,Stephen J Nicholls,Mark Y Chan,Mark D Muthiah,Arun Sanyal,Laurence S Sperling
{"title":"心血管-肝脏-代谢健康:通过改进德尔菲法筛查、诊断和管理心血管疾病中代谢功能障碍相关脂肪变性肝病的建议","authors":"Nicholas W S Chew,Anurag Mehta,Rachel Sze Jen Goh,Audrey Zhang,Yiming Chen,Bryan Chong,Han Shi Jocelyn Chew,Asim Shabbir,Adrian Brown,Georgios K Dimitriadis,Daniel Q Huang,Roger Foo,Carel W le Roux,Gemma A Figtree,Marat Fudim,Ambarish Pandey,Mamas A Mamas,Derek J Hausenloy,A Mark Richards,Stephen J Nicholls,Mark Y Chan,Mark D Muthiah,Arun Sanyal,Laurence S Sperling","doi":"10.1161/circulationaha.124.070535","DOIUrl":null,"url":null,"abstract":"There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and MASLD highlight the multisystem consequences of poor cardiovascular-liver-metabolic health. Metabolic dysfunction and associated insulin resistance, together with the predilection for ectopic fat deposition in the liver and surrounding tissues, are associated with elevated risk of endothelial dysfunction, systemic inflammatory response, and ectopic fat deposition in the epicardium. This complex pathophysiology can accelerate atherogenic dyslipidemia, atherogenesis, diastolic dysfunction, valvular calcification, and cardiac arrhythmias. Despite the mounting evidence of mechanistic pathways underpinning MASLD and CVD, current recommendations have not clearly focused upon MASLD as a risk factor or target for intervention in CVD. We have brought together a diverse range of international experts committed to promoting cardiovascular-liver-metabolic health and related outcomes across the globe. The overarching goal of this document is to offer a construct for clinicians in the cardiovascular field with regards to (1) diagnosis and screening of MASLD through the use of noninvasive serum and imaging tests; (2) screening for CVD in all individuals with MASLD regardless of established atherosclerotic risk factors; and (3) the approach to management of MASLD with respect to prevention of CVD through lifestyle, as well as pharmacologic and surgical strategies. To achieve this, the modified Delphi method was applied and a series of evidence-based quality standard recommendations have been identified.","PeriodicalId":10331,"journal":{"name":"Circulation","volume":"14 1","pages":"98-119"},"PeriodicalIF":35.5000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.\",\"authors\":\"Nicholas W S Chew,Anurag Mehta,Rachel Sze Jen Goh,Audrey Zhang,Yiming Chen,Bryan Chong,Han Shi Jocelyn Chew,Asim Shabbir,Adrian Brown,Georgios K Dimitriadis,Daniel Q Huang,Roger Foo,Carel W le Roux,Gemma A Figtree,Marat Fudim,Ambarish Pandey,Mamas A Mamas,Derek J Hausenloy,A Mark Richards,Stephen J Nicholls,Mark Y Chan,Mark D Muthiah,Arun Sanyal,Laurence S Sperling\",\"doi\":\"10.1161/circulationaha.124.070535\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and MASLD highlight the multisystem consequences of poor cardiovascular-liver-metabolic health. Metabolic dysfunction and associated insulin resistance, together with the predilection for ectopic fat deposition in the liver and surrounding tissues, are associated with elevated risk of endothelial dysfunction, systemic inflammatory response, and ectopic fat deposition in the epicardium. This complex pathophysiology can accelerate atherogenic dyslipidemia, atherogenesis, diastolic dysfunction, valvular calcification, and cardiac arrhythmias. Despite the mounting evidence of mechanistic pathways underpinning MASLD and CVD, current recommendations have not clearly focused upon MASLD as a risk factor or target for intervention in CVD. We have brought together a diverse range of international experts committed to promoting cardiovascular-liver-metabolic health and related outcomes across the globe. The overarching goal of this document is to offer a construct for clinicians in the cardiovascular field with regards to (1) diagnosis and screening of MASLD through the use of noninvasive serum and imaging tests; (2) screening for CVD in all individuals with MASLD regardless of established atherosclerotic risk factors; and (3) the approach to management of MASLD with respect to prevention of CVD through lifestyle, as well as pharmacologic and surgical strategies. To achieve this, the modified Delphi method was applied and a series of evidence-based quality standard recommendations have been identified.\",\"PeriodicalId\":10331,\"journal\":{\"name\":\"Circulation\",\"volume\":\"14 1\",\"pages\":\"98-119\"},\"PeriodicalIF\":35.5000,\"publicationDate\":\"2024-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Circulation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/circulationaha.124.070535\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/circulationaha.124.070535","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

代谢功能障碍相关的脂肪变性肝病(MASLD)的广泛性质及其与心血管疾病(CVD)的联系有了新的认识。这促进了心脏病学家、肝病学家、内分泌学家和更广泛的多学科团队之间的合作,以解决早期识别心血管疾病风险增加的MASLD患者的需求。病理生理过程的重叠以及心血管疾病、代谢综合征和MASLD的平行流行突出了心血管-肝脏-代谢健康不良的多系统后果。代谢功能障碍和相关的胰岛素抵抗,以及肝脏和周围组织中脂肪异位沉积的偏好,与内皮功能障碍、全身炎症反应和心外膜脂肪异位沉积的风险升高有关。这种复杂的病理生理可加速动脉粥样硬化性血脂异常、动脉粥样硬化、舒张功能障碍、瓣膜钙化和心律失常。尽管有越来越多的证据表明MASLD和CVD的机制途径,但目前的建议并没有明确地将MASLD作为心血管疾病干预的危险因素或目标。我们汇集了致力于在全球范围内促进心血管-肝脏代谢健康和相关结果的各种国际专家。本文的总体目标是为心血管领域的临床医生提供一个关于(1)通过使用无创血清和影像学检查诊断和筛查MASLD的框架;(2)对所有MASLD患者进行CVD筛查,而不考虑已确定的动脉粥样硬化危险因素;(3)通过生活方式预防心血管疾病,以及药物和手术策略来管理MASLD的方法。为了实现这一目标,采用了改进的德尔菲法,并确定了一系列循证质量标准建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.
There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and MASLD highlight the multisystem consequences of poor cardiovascular-liver-metabolic health. Metabolic dysfunction and associated insulin resistance, together with the predilection for ectopic fat deposition in the liver and surrounding tissues, are associated with elevated risk of endothelial dysfunction, systemic inflammatory response, and ectopic fat deposition in the epicardium. This complex pathophysiology can accelerate atherogenic dyslipidemia, atherogenesis, diastolic dysfunction, valvular calcification, and cardiac arrhythmias. Despite the mounting evidence of mechanistic pathways underpinning MASLD and CVD, current recommendations have not clearly focused upon MASLD as a risk factor or target for intervention in CVD. We have brought together a diverse range of international experts committed to promoting cardiovascular-liver-metabolic health and related outcomes across the globe. The overarching goal of this document is to offer a construct for clinicians in the cardiovascular field with regards to (1) diagnosis and screening of MASLD through the use of noninvasive serum and imaging tests; (2) screening for CVD in all individuals with MASLD regardless of established atherosclerotic risk factors; and (3) the approach to management of MASLD with respect to prevention of CVD through lifestyle, as well as pharmacologic and surgical strategies. To achieve this, the modified Delphi method was applied and a series of evidence-based quality standard recommendations have been identified.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Circulation
Circulation 医学-外周血管病
CiteScore
45.70
自引率
2.10%
发文量
1473
审稿时长
2 months
期刊介绍: Circulation is a platform that publishes a diverse range of content related to cardiovascular health and disease. This includes original research manuscripts, review articles, and other contributions spanning observational studies, clinical trials, epidemiology, health services, outcomes studies, and advancements in basic and translational research. The journal serves as a vital resource for professionals and researchers in the field of cardiovascular health, providing a comprehensive platform for disseminating knowledge and fostering advancements in the understanding and management of cardiovascular issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信